Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Momen Nassani"'
Autor:
Samar Alfaqawi, Mostafa Mohammed Saleh, Ahmed Kotb, Ghada Abdallah, Leena Ali, Reem Alasbali, Taimor Hussain, Haroon Alfadhil, Ahmed Bin Salman, Momen Nassani, Yazeed Baujaifer, Mohammed I. Sharif, Marwa Nassar, Sarah Samarkandi, Heba Madien, Amal Hejab, Ruah Alyamany, Ahmed Alnughmush, Abdullah Alamer, Ayman Saad, Mansour Alfayez, Abdelwahab Albabtain, Alfadel Alshaibani, Ahmad Alotaibi, Saud Alhayli, Marwan Shaheen, Syed O. Ahmed, Riad Elfakih, Amr Hanbali, Feras Alfraih, Walid Rasheed, Fahad Alsharif, Naeem Chaudhri, Hazza Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Ali Alahmari
Publikováno v:
HemaSphere, Vol 7, p e06488d6 (2023)
Externí odkaz:
https://doaj.org/article/a0b321b6475b4ca8b1e7c3944e1ad24a
Autor:
Momen Nassani, Riad El Fakih, Jakob Passweg, Simone Cesaro, Hazzaa Alzahrani, Ali Alahmari, Carmem Bonfim, Raheel Iftikhar, Amal Albeihany, Constantijn Halkes, Syed Osman Ahmed, Carlo Dufour, Mahmoud Aljurf
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Bone marrow failure syndromes are a heterogeneous group of diseases. With the major advancements in diagnostic tools and sequencing techniques, these diseases may be better classified and therapies may be further tailored. Androgens, a historic group
Externí odkaz:
https://doaj.org/article/363959dddb5e4c4fa7b577fd2a7253ad
Autor:
Momen Nassani, Walid Rasheed, Majed Altareb, Ali Alsharif, Feras Alfraih, Amr Hanbali, Saud Alhayli, Syed Osman Ahmed, Abdulwahab A. Albabtain, Marwan Shaheen, Naeem Chaudhri, Fahad Alsharif, Alfadel Alshaibani, Ahmad S. Alotaibi, Tusneem Elhassan, Fahad Almohareb, Ali Alahmari, Hazzaa Alzahrani, Mahmoud Aljurf, Riad El Fakih
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S436
Autor:
Momen Nassani, Walid Rasheed, Majed Altareb, Ali Alsharif, Feras Alfraih, Amr Hanbali, Saud Alhayli, Syed Osman Ahmed, Abdulwahab A. Albabtain, Marwan Shaheen, Naeem Chaudhri, Fahad Alsharif, Alfadel Alshaibani, Ahmad S. Alotaibi, Tusneem Elhassan, Fahad Almohareb, Ali Alahmari, Hazzaa Alzahrani, Mahmoud Aljurf, Riad El Fakih
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S186
Autor:
Ahmad S. Alotaibi, Shad Ahmed, Walid Rasheed, Marwan Shaheen, Nadiah Alobaidi, Ahmad Alnughmush, Amal Hejab, Taimoor Hussain, Ahmed Abdrabou, Haroon Alfadhil, Mostafa Saleh, Ahmed Bin Salman, Majed Altareb, Momen Nassani, Yazeed S Bajuaifer, Mohamed Isam Sharif, Emad Ghabashi, Shaykhah Alotaibi, Riad Youniss, Alfadel Alshaibani, Ali Alahmari, Saud Alhayli, Riad Elfakih, Feras Al Fraih, Amr Suleiman Hanbali, Fahad Alsharif, Naeem A. Chaudhri, Hazza Alzahrani, Fahed Almhareb, Mahmoud Aljurf, Syed O. Ahmed
Publikováno v:
Blood. 138:1851-1851
Background A significant proportion of patients with acute myeloid leukemia (AML) will either be refractory to initial chemotherapy or will suffer refractory relapse. The role of allogeneic transplantation (SCT) in active disease is contentious. Ther